In 2009, Matusiak, L., Bieniek, A., and Szepietowski, J.C., revealed that levels of TNF-α serum concentration are higher in HS individuals than in healthy controls, which is the first report of increased TNF-α serum concentration in HS patients [25]. This evidence concerns the gene TNF and histiocytic sarcoma.